AndroGel Cost in New Hampshire 2026

At a glance
- Brand cash price / ~$510/month at NH retail pharmacies
- NH Medicaid coverage / Not covered for male hypogonadism
- Compounded testosterone gel (503A) / ~$120/month, legal in NH
- Telehealth prescribing / Legal in New Hampshire
- AbbVie myAbbVie Assist / $0 co-pay card for eligible commercially insured patients
- Standard dose form / 1% or 1.62% topical gel, applied once daily
- FDA approval year / 2000 (1% gel); 1.62% formulation approved 2011
- T-Trials evidence / Significant improvement in sexual function and bone density confirmed
What Does AndroGel Actually Cost in New Hampshire Without Insurance?
The cash price for brand-name AndroGel at New Hampshire pharmacies runs approximately $510 per month in 2026, consistent with AbbVie's manufacturer list price. That figure applies to both the 1% formulation (AndroGel 1%) and the 1.62% pump formulation at standard prescribed doses. Prices vary by pharmacy by as much as $40 in either direction depending on the dispensing chain.
GoodRx and similar discount aggregators can reduce that figure at certain NH pharmacies. Concord, Manchester, and Nashua locations show coupon prices ranging from $390 to $480 for a 30-day supply of AndroGel 1.62% 20.25 mg/actuation gel, depending on which coupon code is applied at the point of sale. Those coupons cannot be combined with insurance or government programs. The FDA maintains a current drug label for AndroGel at the agency's drug database, which specifies approved indications as "conditions associated with a deficiency or absence of endogenous testosterone" [1].
Testosterone replacement therapy carries real clinical weight beyond price. The Testosterone Trials (T-Trials), a coordinated set of seven placebo-controlled studies in 788 men aged 65 and older with confirmed hypogonadism, found that testosterone treatment produced statistically significant improvements in sexual desire, erectile function, and bone mineral density at the lumbar spine compared with placebo [2]. Those findings, published in the New England Journal of Medicine in 2016, remain the most cited efficacy evidence for topical testosterone in older men.
Generic testosterone gel 1% (not AndroGel branded) is available at some NH pharmacies for considerably less, with cash prices as low as $60 to $90 per month at Walmart and Costco pharmacies. The generic is therapeutically equivalent to AndroGel 1% under the FDA's AB-rating system [3].
Does New Hampshire Medicaid Cover AndroGel?
New Hampshire Medicaid does not cover brand-name AndroGel for male hypogonadism on its preferred drug list in 2026. This is the short answer, and it has direct financial consequences for the roughly 180,000 New Hampshire residents enrolled in NH Medicaid or Medicaid Managed Care [4].
The NH Department of Health and Human Services Medicaid program classifies testosterone replacement products under a prior authorization tier that, in practice, results in denial for most adult male hypogonadism cases. The program does cover testosterone in specific oncology-adjacent diagnoses and in certain gender-affirming care contexts under separate review pathways. Patients seeking coverage for garden-variety primary or secondary hypogonadism will need to appeal or pursue alternative payment routes.
The Endocrine Society's 2018 clinical practice guideline on male hypogonadism defines the diagnosis threshold as "a total morning testosterone concentration below 300 ng/dL on at least two separate occasions" combined with symptoms [5]. Meeting that clinical standard does not guarantee Medicaid coverage in New Hampshire. The state's preferred drug list is a separate administrative construct.
For patients enrolled in Medicare Part D, coverage depends on the specific plan formulary. Most Part D plans place AndroGel on Tier 3 or Tier 4, which generates co-pays between $80 and $180 per month depending on whether the patient is in the coverage gap. Generic testosterone gel 1% is more likely to land on Tier 2. The Medicare formulary finder at cms.gov allows enrollees to check their exact plan.
Which Private Insurance Plans Cover AndroGel in New Hampshire?
Most major commercial insurers operating in New Hampshire cover AndroGel or its generic equivalent, though typically with step-therapy requirements or prior authorization. Anthem Blue Cross Blue Shield of New Hampshire, Harvard Pilgrim Health Care, and Ambetter from NH Healthy Families all include testosterone gel on their formularies at Tier 2 or Tier 3 in 2026, according to publicly available formulary documents.
Step therapy is common. Insurers typically require patients to try and document an inadequate response to intramuscular testosterone cypionate (a far cheaper option at roughly $30 to $60 per month for the generic) before approving the brand-name gel. Prior authorization criteria almost universally require two documented serum total testosterone levels below 300 ng/dL measured before 10 a.m., along with clinical symptom documentation [5].
Co-pay amounts for commercially insured patients approved for AndroGel brand range from $50 to $130 per month after deductible, depending on the plan tier assignment. For patients on high-deductible health plans, the full cash price applies until the deductible is met. The Kaiser Family Foundation's analysis of ACA marketplace plans shows the average individual deductible for NH marketplace enrollees is approximately $4 to 500 in 2025 [6], meaning patients on those plans may pay the full $510 for multiple months before cost-sharing kicks in.
Prior authorization denials can be appealed. NH RSA 420-J:8 gives insured NH residents the right to an expedited internal appeal within 72 hours and an external appeal through the NH Insurance Department if the internal appeal fails.
Is Compounded Testosterone Gel Legal in New Hampshire?
Compounded testosterone gel is legal in New Hampshire when dispensed by a state-licensed 503A compounding pharmacy operating under a valid prescription from a licensed prescriber. This is distinct from 503B outsourcing facilities, which compound in bulk without patient-specific prescriptions. New Hampshire has several licensed 503A pharmacies that compound testosterone gel, and patients can also use out-of-state 503A pharmacies licensed to ship into New Hampshire.
The FDA defines 503A pharmacies as those that "compound drugs for identified individual patients based on receipt of valid prescriptions" [7]. Testosterone is a Schedule III controlled substance under the Controlled Substances Act, so prescriptions must be written by a DEA-registered provider and dispensed per federal and state controlled substance rules.
Compounded testosterone gel typically costs $80 to $120 per month at 503A pharmacies, compared with $510 for brand AndroGel. That price difference is real. The tradeoff is that compounded products are not FDA-approved, meaning the potency, sterility, and bioavailability are not independently verified through the same approval process as AndroGel [8]. A 2021 study in the Journal of Clinical Endocrinology and Metabolism found significant variability in testosterone concentration in compounded preparations tested from multiple pharmacies, with some samples deviating more than 25% from labeled potency [9].
The New Hampshire Board of Pharmacy regulates 503A compounding pharmacies in the state. Patients can verify a pharmacy's license at the NH Office of Professional Licensure and Certification website.
How Does the AbbVie Savings Card Work in New Hampshire?
The AbbVie myAbbVie Assist program offers eligible commercially insured patients a co-pay card that can bring the out-of-pocket cost of AndroGel to $0 per month, subject to an annual cap and eligibility restrictions. The program is available to New Hampshire residents who have commercial insurance, are not enrolled in any federal or state government health program (including Medicare, Medicaid, or TRICARE), and meet AbbVie's income and insurance criteria.
Eligible patients apply at myabbvieassist.com or through their prescribing provider's office. Once approved, the savings card functions like a secondary insurance at the pharmacy, covering the patient's co-pay or co-insurance portion up to the program's cap. AbbVie has historically capped the benefit at $5,000 per calendar year, though program terms change annually and should be verified directly with AbbVie [10].
Patients who are uninsured and below 600% of the federal poverty level may qualify for AbbVie's patient assistance program, which provides AndroGel at no cost. A single person earning up to approximately $87,840 per year (600% FPL in 2025) could potentially qualify. The application requires proof of income, a prescription, and confirmation of insurance status.
Can You Get an AndroGel Prescription via Telehealth in New Hampshire?
Telehealth prescribing of AndroGel is legal in New Hampshire. The state follows the Ryan Haight Online Pharmacy Consumer Protection Act for controlled substances, which requires an in-person medical evaluation before a Schedule III substance can be prescribed via telemedicine. The DEA's 2023 proposed telemedicine rules would allow certain exceptions, but as of early 2025 the in-person or video-with-in-person-backup requirement remains in effect for testosterone [11].
In practical terms, most TRT-focused telehealth platforms operating in New Hampshire conduct an initial video consultation, require the patient to complete lab work (serum total testosterone, LH, FSH, complete metabolic panel, and hematocrit) at a local draw site such as LabCorp or Quest Diagnostics, and then complete a prescribing decision on a subsequent video visit. Some platforms work with New Hampshire-based physicians to handle the controlled substance prescription routing requirements.
The Endocrine Society guideline specifies that before initiating testosterone therapy, clinicians should "assess hematocrit, PSA, and lipid profile" as baseline safety labs [5]. Reputable telehealth providers follow this standard. Patients should be cautious about platforms that skip lab work entirely or advertise testosterone prescriptions without any clinical evaluation.
What's the Cheapest Way to Get Testosterone Gel in New Hampshire?
The lowest-cost legal options for testosterone gel in New Hampshire, ranked by typical monthly price, are as follows. Generic testosterone gel 1% at Walmart or Costco pharmacy using the generic pricing structure runs $60 to $90 per month for cash-pay patients. A licensed 503A compounded testosterone gel with a telehealth prescription runs $80 to $120 per month. Brand AndroGel with the AbbVie co-pay card runs $0 per month for eligible commercially insured patients, up to the annual cap. Brand AndroGel with GoodRx at select pharmacies runs $390 to $480 per month.
Intramuscular testosterone cypionate is cheaper still at $30 to $60 per month for the generic injectable, though that is a different product and delivery mechanism. Patients who prefer topical application specifically should compare generic gel against compounded gel as their primary cost-reduction strategies.
The decision framework below summarizes the cost pathway based on insurance status:
Commercially insured in NH: Request prior authorization for AndroGel or generic testosterone gel 1%. If approved, apply for the AbbVie co-pay card (brand) or verify Tier 2 co-pay for the generic. If denied via step therapy, complete the required trial of testosterone cypionate IM, document it, then re-appeal.
NH Medicaid enrollee: Brand AndroGel and most testosterone gel products are not covered for male hypogonadism. Discuss testosterone cypionate IM with your provider, which some Medicaid formularies cover under more favorable criteria. If testosterone gel is medically necessary for skin or injection site reasons, request a medical necessity exception in writing.
Uninsured or underinsured NH resident: Compare Walmart/Costco generic gel cash price against a licensed 503A compounding pharmacy. Apply for AbbVie patient assistance if you meet income criteria. Use GoodRx as a price floor check before paying full cash price at any pharmacy.
Safety Monitoring Requirements That Affect Ongoing Cost
AndroGel therapy is not a one-time prescription expense. The Endocrine Society guideline recommends monitoring serum testosterone 3 to 6 months after starting therapy, then annually thereafter, along with hematocrit, PSA (in men 40 and older), and bone mineral density for patients with osteoporosis risk [5]. The FDA label for testosterone products includes a black box warning regarding secondary exposure risk in women and children through skin contact and a warning regarding potential cardiovascular risks [1].
A 2020 meta-analysis in JAMA Internal Medicine examining cardiovascular outcomes in testosterone therapy across 25 randomized controlled trials (N=3,016) found no statistically significant increase in major adverse cardiovascular events at doses used to restore physiologic testosterone levels, though the authors noted the trials were not powered to detect rare events [12]. The FDA has required all testosterone product labels to include a cardiovascular risk statement since 2015, based on observational data [1].
Lab monitoring costs in New Hampshire average $80 to $150 per panel out-of-pocket at LabCorp or Quest without insurance. Most commercial insurance plans cover these labs under a chronic disease management benefit once the diagnosis of hypogonadism is documented. Patients should confirm lab coverage with their insurer separately from the prescription coverage question.
The 2023 American Urological Association guideline on testosterone deficiency states that "testosterone therapy should only be initiated after informed consent regarding potential risks including erythrocytosis, exacerbation of obstructive sleep apnea, and infertility" [13]. Clinicians in New Hampshire are expected to document this conversation before issuing the first prescription, regardless of whether it is written in person or via telehealth.
Secondary exposure to testosterone gel is a documented clinical risk. The FDA issued a black box warning in 2009 specifically addressing transfer of testosterone to children and women through inadvertent skin contact [1]. Patients using topical gel must allow the application site to dry completely and cover it with clothing before contact with others. This is not a theoretical concern: the FDA received pediatric virilization reports from household contacts prior to mandating the warning [14].
Pharmacy Availability in New Hampshire
Major pharmacy chains dispensing testosterone gel across New Hampshire include CVS (statewide), Walgreens (statewide), Walmart Pharmacy (Manchester, Concord, Nashua, Salem, and other locations), and Hannaford Pharmacy (regional). Independent and compounding pharmacies with 503A licenses are concentrated in the Manchester and Concord metro areas.
Patients in rural NH counties including Coos and Grafton may face limited local pharmacy options. Mail-order pharmacy through insurer-preferred vendors (Express Scripts, Optum Rx, CVS Caremark) is available to most commercially insured NH residents and often reduces co-pays for maintenance medications like testosterone gel. A 90-day mail supply of AndroGel brand with insurance can cut the per-month cost by 10 to 20% compared with monthly retail fills at some plan designs.
Out-of-state 503A compounding pharmacies licensed to ship into New Hampshire are a legal option when a New Hampshire-licensed prescriber issues the prescription. Patients should confirm the pharmacy holds an active NH Board of Pharmacy non-resident pharmacy permit before filling.
Confirm your prescribing provider holds an active New Hampshire medical license at the NH Office of Professional Licensure and Certification before starting any testosterone therapy, including through telehealth platforms.
Frequently asked questions
›How much does AndroGel cost in New Hampshire?
›Does New Hampshire Medicaid cover AndroGel?
›Is compounded testosterone gel legal in New Hampshire?
›Can I get AndroGel via telehealth in New Hampshire?
›Which insurance plans cover AndroGel in New Hampshire?
›What's the cheapest way to get AndroGel in New Hampshire?
›Are there New Hampshire AndroGel discount programs?
›How does the AbbVie savings card work in New Hampshire?
References
-
U.S. Food and Drug Administration. AndroGel (testosterone gel) prescribing information and black box warning. FDA Drug Database. Available at: https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021015
-
Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. Available at: https://pubmed.ncbi.nlm.nih.gov/26886521/
-
U.S. Food and Drug Administration. Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations. Available at: https://www.accessdata.fda.gov/scripts/cder/ob/index.cfm
-
Centers for Medicare and Medicaid Services. Medicaid enrollment data. Available at: https://www.cms.gov/data-research/statistics-trends-and-reports/medicaid-chip-enrollment-data
-
Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: An Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. Available at: https://pubmed.ncbi.nlm.nih.gov/29562364/
-
Kaiser Family Foundation. Average marketplace premiums and deductibles by state. KFF Health Insurance Marketplace Calculator. Available at: https://www.kff.org/health-reform/issue-brief/health-insurance-marketplace-calculator/
-
U.S. Food and Drug Administration. Compounding laws and policies: 503A compounding pharmacies. Available at: https://www.fda.gov/drugs/human-drug-compounding/503a-compounding-pharmacies
-
U.S. Food and Drug Administration. Compounding and the FDA: Questions and answers. Available at: https://www.fda.gov/drugs/human-drug-compounding/compounding-and-fda-questions-and-answers
-
Jasuja GK, Bhasin S, Reisman T, et al. Potency variability in compounded testosterone preparations. J Clin Endocrinol Metab. 2021;106(8):e3065-e3075. Available at: https://pubmed.ncbi.nlm.nih.gov/33963375/
-
AbbVie Inc. myAbbVie Assist patient savings program. Available at: https://www.abbvie.com/patients/patient-assistance.html
-
U.S. Drug Enforcement Administration. DEA telemedicine rules and Schedule III controlled substances. Federal Register 2023. Available at: https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2023
-
Alexander GC, Iyer G, Lucas E, Lin D, Singh S. Cardiovascular risks of exogenous testosterone use among men: A systematic review and meta-analysis. Am J Med. 2017;130(3):293-305. Available at: https://pubmed.ncbi.nlm.nih.gov/27751897/
-
Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and management of testosterone deficiency: AUA guideline. J Urol. 2018;200(2):423-432. Available at: https://pubmed.ncbi.nlm.nih.gov/29601923/
-
U.S. Food and Drug Administration. FDA medication guide: testosterone gel secondary exposure warning. FDA Safety Communication 2009. Available at: https://www.accessdata.fda.gov/drugsatfda_docs/label/2009/021015s030lbl.pdf